Alkem’s Mandva API Plant Clears USFDA Audit With Zero 483s
Alkem Laboratories’ Mandva API facility cleared a five-day USFDA inspection (26–30 October 2026) with no Form 483 observations, a cleaner result than the site’s 2023 audit.
Alkem Laboratories’ Mandva API facility cleared a five-day USFDA inspection (26–30 October 2026) with no Form 483 observations, a cleaner result than the site’s 2023 audit.
Speaking at India Pharma Expo 2026, H. E. Gareth Wynn Owen, British Deputy High Commissioner, highlighted the transformative potential of […]
India’s pharmaceutical sector is entering a transformative phase, driven by innovation, digital technologies, regulatory reforms, and a renewed focus on […]